GSK3B and Cognitive impairment: Our finding that this reduction was significantly greater in the lithium group than in the placebo group is consistent with the lithium-induced reduction of the IL-6 level via PI3K/Akt/GSK-3β pathway regulation observed in animal models of cognitive impairment, including mouse models of MCI and dementia62,96–102.